£201.25

Humana - The Dopamine Receptors Reference Book

Price data last checked 38 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£201 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 53 days • 53 data points (No recent data available)

Historical
Generating forecast...
£201.25 £191.19 £195.21 £199.24 £203.26 £207.29 £211.31 14 March 2026 27 March 2026 09 April 2026 22 April 2026 05 May 2026

Price Distribution

Price distribution over 53 days • 1 price levels

Days at Price
53 days 0 13 27 40 53 £201 Days at Price

Price Analysis

Most common price: £201 (53 days, 100.0%)

Price range: £201 - £201

Price levels: 1 different prices over 53 days

Description

The Dopamine Receptors (The Receptors) by Humana provides an essential reference for understanding one of the most validated drug targets in neuropsychiatric medicine. As key sites of action for treatments related to schizophrenia and Parkinson's disease, dopamine receptors play a central role in medical research and pharmacology. This updated edition expands upon the successful first edition to cover a broad range of clinical interests. It explores how these receptors serve as drug targets or potential targets for various conditions, including depression, substance abuse, Tourette's syndrome, and attention deficit hyperactivity disorder (ADHD). Designed for professionals in pharmacy and allied health, this work highlights the most active areas of current research. By connecting fundamental receptor science with modern therapeutic applications, it serves as a comprehensive guide for those studying the mechanisms of neuropsychiatric disorders and drug development.

Key Features

Comprehensive reference work covering dopamine receptors as validated drug targets for neuropsychiatric disorders.

Updated content from the successful first edition to include the most active areas of current research.

Detailed insights into receptor roles in treating schizophrenia and Parkinson's disease.

Explores potential drug targets for depression, substance abuse, and Tourette's syndrome.

Provides essential information regarding attention deficit hyperactivity disorder (ADHD) research.

Written by specialized authors to provide a deep look into modern pharmaceutical research areas.

Product Specifications

Brand
Humana
Format
hardcover
Domain
Amazon UK
Release Date
05 November 2009
Listed Since
02 August 2007

Barcode

No barcode data available

Similar Products You Might Like

The Dopamine Receptors (The Receptors)
100% match

The Dopamine Receptors (The Receptors)

Humana

£207.55 12 Jan 2026
Dopamine (Volume 21) (Handbook of Chemical Neuroanatomy, Volume 21)
97% match

Dopamine (Volume 21) (Handbook of Chemical Neuroanatomy, Volume 21)

Elsevier

£280.00 25 Jan 2026
The Handbook of Dopamine (Volume 32) (Handbook of Behavioral Neuroscience, Volume 32)
97% match

The Handbook of Dopamine (Volume 32) (Handbook of Behavioral Neuroscience, Volume 32)

Academic Press

£171.96 24 Jan 2026
Dopamine in the CNS: Pt. 1 (Handbook of Experimental Pharmacology)
97% match

Dopamine in the CNS: Pt. 1 (Handbook of Experimental Pharmacology)

Springer

£80.56 29 Mar 2026
Das dopaminerge Verstärkungssystem: Funktion, Interaktion mit anderen Neurotransmittersystemen und psychopathologische Korrelate: 100 (Monographien aus dem Gesamtgebiete der Psychiatrie, 100)
97% match

Das dopaminerge Verstärkungssystem: Funktion, Interaktion mit anderen Neurotransmittersystemen und psychopathologische Korrelate: 100 (Monographien aus dem Gesamtgebiete der Psychiatrie, 100)

Springer

£57.66 02 Mar 2026
Therapeutic Applications of Dopamine D3 Receptor Function: New Insight After 30 Years Of Research: 60 (Current Topics in Behavioral Neurosciences, 60)
97% match

Therapeutic Applications of Dopamine D3 Receptor Function: New Insight After 30 Years Of Research: 60 (Current Topics in Behavioral Neurosciences, 60)

Springer

£97.73 04 Apr 2026
Das dopaminerge Verstärkungssystem: Funktion, Interaktion mit anderen Neurotransmittersystemen und psychopathologische Korrelate: 100 (Monographien aus dem Gesamtgebiete der Psychiatrie, 100)
97% match

Das dopaminerge Verstärkungssystem: Funktion, Interaktion mit anderen Neurotransmittersystemen und psychopathologische Korrelate: 100 (Monographien aus dem Gesamtgebiete der Psychiatrie, 100)

Springer

£71.13 03 Mar 2026
Dopamine Receptors and Transporters, 2nd Ed - CRC Press
97% match

Dopamine Receptors and Transporters, 2nd Ed - CRC Press

CRC Press

£136.61 10 May 2026
New Developments in Dopamine Research
97% match

New Developments in Dopamine Research

£104.99 25 Feb 2026
Imaging Dopamine
96% match

Imaging Dopamine

Cambridge University Press

£71.25 10 May 2026
Dopamine Research Advances - Nova Science Pub Inc Book
96% match

Dopamine Research Advances - Nova Science Pub Inc Book

Brand: Nova Science Pub Inc

£47.96 10 May 2026
Dopamine (Volume 211) (Progress in Brain Research, Volume 211)
96% match

Dopamine (Volume 211) (Progress in Brain Research, Volume 211)

Elsevier

£172.38 26 Jan 2026
Dopamine Receptor Technologies: 96 (Neuromethods, 96)
96% match

Dopamine Receptor Technologies: 96 (Neuromethods, 96)

Humana

£79.65 13 Apr 2026
Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance (Progress in Brain Research): 172
96% match

Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance (Progress in Brain Research): 172

Elsevier

£178.29 11 Mar 2026
Cardiovascular Function of Peripheral Dopamine Receptors: 15 (Clinical Pharmacology)
96% match

Cardiovascular Function of Peripheral Dopamine Receptors: 15 (Clinical Pharmacology)

CRC Press

£100.38 10 Jun 2026
Humana Dopamine: Methods and Protocols: 964 (Methods in Molecular Biology)
96% match

Humana Dopamine: Methods and Protocols: 964 (Methods in Molecular Biology)

Humana

£101.36 01 May 2026
Dopamine Home: A bold guide to mood-boosting interiors
96% match

Dopamine Home: A bold guide to mood-boosting interiors

Greenfinch

£16.02 18 Mar 2026
Life's rewards: Linking dopamine, incentive learning, schizophrenia, and the mind
95% match

Life's rewards: Linking dopamine, incentive learning, schizophrenia, and the mind

Oxford University Press

£42.50 10 May 2026
5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)
95% match

5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)

Humana

£145.63 10 Mar 2026
Integrating the Neurobiology of Schizophrenia: 78 (International Review of Neurobiology.): Volume 78
95% match

Integrating the Neurobiology of Schizophrenia: 78 (International Review of Neurobiology.): Volume 78

Academic Press

£105.85 20 Apr 2026
Dopaminergic System Function and Dysfunction: Experimental Approaches: 193 (Neuromethods, 193)
95% match

Dopaminergic System Function and Dysfunction: Experimental Approaches: 193 (Neuromethods, 193)

Humana

£155.70 31 Jan 2026
Dopaminergic System Function and Dysfunction: Experimental Approaches: 193 (Neuromethods, 193)
95% match

Dopaminergic System Function and Dysfunction: Experimental Approaches: 193 (Neuromethods, 193)

Humana

£110.07 31 Jan 2026
Dopamine Nation: Why our Addiction to Pleasure is Causing us Pain
94% match

Dopamine Nation: Why our Addiction to Pleasure is Causing us Pain

Headline Home

£6.53 27 Jan 2026
Neurobiology of DOPA as a Neurotransmitter
94% match

Neurobiology of DOPA as a Neurotransmitter

CRC Press

£230.00 31 Jan 2026